Cedars-Sinai (1).png

Gemelli Biotech is proud to partner closely with Cedars-Sinai in Los Angeles, ranked by US News and World Report as one of the top 10 hospitals in the nation. The Medically Associated Science and Technology (MAST) program at Cedars-Sinai is dedicated to the development of lab tests, drugs and devices to diagnose and treat patients.

Partnership with MAST allows Gemelli to operate on the cutting edge, with an early look at the newest scientific discoveries related to the microbiome and the ability to draw on MAST’s expertise in navigating the US Food and Drug Administration approval process.

Visit the Cedars-Sinai Website

Visit the MAST Website


Gemelli Biotech partners with Kuwait-based Advanced Medical German Co. to distribute ibs-smart™ in major territories in the Middle East and North Africa, including Kuwait, United Arab Emirates, Qatar, Saudi Arabia, Egypt and Turkey, among others.

Visit the AMG Company website.

Gemelli Biotech and Swiss-based Unilabs and have partnered to distribute ibs-smart™ in Swizerland.

Visit the Unilabs website.

Gemelli Biotech's ibs-smart™ is available in Mexico through a partnership with Mexico City-based Biomedica de Referencia. 

Visit the Biomedica website.

Gemelli Biotech has partnered with Castellon-based Laboratoria Calderon to distribute ibs-smart™ in Spain. 

Visit the Laboratoria Calderon website.